The completion of the trial allows Lilly to seek regulatory approval and potentially launch the next-generation drug in 2027 as it competes with Novo Nordisk in the obesity treatment market
This ensures proper monitoring, support and safety
Wegovy Contrave (naltrexone/bupropion): Contrave is a combination of naltrexone, which is used to manage substance use disorder, and bupropion, an antidepressant that also helps with smoking cessation
Table 15: Analysis of the Composite 3 point MACE and Individual Cardiovascular Endpoints in DEVOTE Figure 3: Cumulative Event Probability for Time to First MACE in DEVOTE Hypoglycemia Outcomes Patients with T2DM and Atherosclerotic CVD The pre-specified secondary endpoints of event and incidence rates of severe hypoglycemia were sequentially tested
Por eso, ms all de lo que leas en internet, lo esencial es que un especialista valore tu situacin
Traveling internationally with Wegovy Before traveling internationally with Wegovy, consider checking with the embassy of the country youre visiting for its medication regulations